Close

Ratings by Leerink Partners

Date Analyst CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/16/2024 Joseph Schwartz Ultragenyx Pharma RARE Maintain Outperform
(N/A)
N/A
(N/A)
 
 
  Details
5/15/2024 Daina Graybosch Bolt Biotherapeutics, Inc. BOLT Downgrade Market Perform
(Outperform)
1.00
(3.00)
1.33
(0.79)
-40.6% Details
3,309 more...